CSIMarket
 
Abbott Laboratories  (ABT)
 

Facing demanding business enviroment, with rather steep -12.007 %, Revenues decrease, the ABT over the most recent fiscal period

Abbott Laboratories reported fourth quarter of 2022 operating surplus of $1304 million


Published Mar 25 2023
CSIMarket Team / CSIMarket.com


pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_CommonsIn the fourth quarter of 2022 financial report the company declared soft top and bottom-line, where income per share plummeted by -46.9 % and revenue by -12.007 % year on year. Revenue were to $10.09 billions relative to $11.47 billions eps at $0.59 in contrast to $1.12 in the comparable interval a year prior.

From the previous quarter, income faded by -26.84 % from $0.81 per share and Revenue decreased by -3.064 % from $10.41 billions.


Earnings of $1,033.000 millions in the financial interval closing December 31 2022 fell by -48.06 % from $1,989.000 millions in the corresponding period a year before. Looking further into financial interval closing December 31 2022 Abbott Laboratories's profitability, operating margin mitigated to 12.92%, and net margin shrank to 10.24%.
Operating earnings, fell -45.16% to $1304 millions, squeezing Abbott Laboratories's operating margin to 12.92%, from 20.74% in the fourth quarter of 2021. Studying more the operating results for the fiscal 12 Months 2022, ABT announced Revenues of $43.65 billions and earnings of $6.93 billions.

Major Pharmaceutical Preparations company mentioned as well, that Eps decreased by -0.76 % to $3.91 per share from $3.94 in the prior fiscal 12 Months , contributesRevenues increased by 1.34 % from $43.08 billions a year prior.

Abbott Laboratories is expected to report next financial earnings on May 02, 2023.



Abbott Laboratories's Price to Book ratio

Abbott Laboratories's ROE



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com